MENU

Articles for Indivior (LSE: INDV)

2 growth champions I’d buy and hold for two decades

These companies have room to expand rapidly over the next 20 years. More »

2 FTSE 250 pharma stocks I’d buy today and hold for another five years

Roland Head takes a look at two unusual pharma stocks with long-term growth potential. More »

2 stocks I’d invest £1,000 in right now

If you are looking for decent share ideas, check out these two that reported on Thursday. More »

2 no-brainer stocks I’d buy in pharma

Royston Wild reveals two pharma stocks with the capability to deliver knockout profits growth. More »

2 monster stocks in the making I’d buy today

These two shares could post high total returns. More »

2 growth stocks I’d buy and hold for 2018

Roland Head takes a look at two promising growth stocks from his watch list. More »

2 soaring growth stocks I’d consider buying today

These two stocks have grown strongly in recent years and Harvey Jones expects further progress. More »

Why this beaten-up FTSE 100 dividend stock could be a bargain

Roland Head explains why he'd buy this 6% yielder from the FTSE 100 (INDEXFTSE:UKX). More »

Why I think Indivior plc is a growth stock for shrewd investors

You shouldn't count out Indivior plc (LSE: INDV) just yet. More »

Why I’d avoid Indivior plc today after shares crash 35%

Indivior plc (LON: INDV) is one of today's major fallers. More »

This great value stock is a better bet than Sirius Minerals plc

Royston Wild looks at a stock with more investment appeal than Sirius Minerals plc (LON: SXX). More »

2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements? More »

These 2 FTSE 250 flyers are up 60% in just 12 months

Investors in these two FTSE 250 (INDEXFTSE:MCX) companies have plenty to celebrate, says Harvey Jones. More »

2 top value stocks you should consider buying right now

Royston Wild runs the rule over two white-hot bargain stocks. More »

Will this spin-off stock continue to slay FTSE 100 giants?

Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk. More »

2 fast-growing FTSE 250 stocks for a prosperous 2017

It could pay to take a closer look at these surprise winners, says Roland Head. More »

Why AstraZeneca plc may still not be cheap enough to beat this upstart

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative. More »

The Good, the Bad and the Ugly of pharma stocks

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector. More »

Should you snap up these two big fallers today?

We've got some big movers today, and share price falls can lead to nice bargains. Are these two worth snapping up? More »

3 hot shares to buy after today’s gains?

An unexpected share price movement could signal time to buy. More »